ATC code H04

ATC code H04 Pancreatic hormones is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup H04 is part of the anatomical group H Systemic hormonal preparations, excluding sex hormones and insulins.[4]

ATC codes
H Systemic hormonal preparations, excluding sex hormones and insulins
H01 Pituitary and hypothalamic hormones and analogues
H02 Corticosteroids for systemic use
H03 Thyroid therapy
H04 Pancreatic hormones
H05 Calcium homeostasis

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QH04.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

H04A Glycogenolytic hormones

H04AA Glycogenolytic hormones
H04AA01 Glucagon

References
  1. "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. "ATC/DDD Index 2022: code H04". WHO Collaborating Centre for Drug Statistics Methodology.
  5. "ATCvet Index 2022: code QH04". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.